chrisvoncsefalvay/vaers-outcomes huggingface dataset:
10:30 pm same day/night -- extreme cold; dizziness; 4 fainting spells; head rush-inflamation extreme the next day and Saturday.  I found myself looking up at the ceiling 4 times during the night after fainting dead away.  Frightening as that has never happened to me before.  It was the weekend; I was unable to reach any doctor for advice.   Plus with a major snow storm we were snowed in and I couldn't get out.  This was the sickest I've ever been in my life!
tingling tongue, hypertension (172-111) Tx: vitals, monitored allergy consult given -> Employee missed appt
Mom noted rash started 11/4/07. Patient now has red papules, vesicles and scabbed lesions primarily to head spreading to trunk. No temp at present.
About two weeks after first moderna does I ended up having Shingles.  A ton of pain  and rash in the middle of my back down right shoulder and right arm. Was treated on 1/31 at urgent care with antiviral and gapapentin  for pain. So far its been about 3 weeks..rash has scabbed still having some itching and pain.
Information has been received from a patient's mother concerning her 7.5 year old daughter with no allergies or pertinent medical history who was vaccinated with all three doses of MMR II SQ. The patient has received titer test revealing that she is not protected from the mumps at this time. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been received from a patient's mother indication that the physician will give the patient another dose of MMR II because the mumps virus vaccine (MSD) is not available until 2009. Additional information has been received from a physician concerning the 7 year old female patient who on 16-MAY-2002 was vaccinated with the first dose of MMR II (lot# 636580/1273L, is valid for VARIVAX, not MMR II, on 26-SEP-2005, was vaccinated with the second dose of MMR II (Lot# 648677/0555P). On 26-SEP-2005, the patient also received DTAP-IPV. On 16-MAY-2002, the patient also received Varicella virus vaccine live (manufacturer unknown). In August 2008, the patient has a Mumps IgG testing, and the outcome was negative. The patient requested Mumps vaccine. No further information is available.
Pt reported a fever 103-104 F on Sat 3/21/09. He also C/O abdomen discomfort X vomited x1 and backache.
first dose of Shingrix a couple years ago and wants to know if it's okay to send them back for the second shot; This non-serious case was reported by a physician via call center representative and described the occurrence of incomplete course of vaccination in an unspecified number of patients who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose a couple years ago).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: first dose of Shingrix a couple years ago and wants to know if it's okay to send them back for the second shot).The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 30-AUG-2023 The reporter had some patients that got the first dose of Shingrix a couple years ago and wanted to know if it was okay to send them back for the second shot after more than 6 months has passed or if they need to restart the series. No additional information was available and unknown if follow up was permissible. Till the time of reporting, the patients did not receive the 2nd dose of Shingrix, which led to incomplete course of vaccination.
Patient received two doses of Janssen vaccine. No adverse event has been noticed at the time of reporting.  Patient is an inmate at the time of administration of the second dose of vaccine on 07/20/2021. When asked if the individual had received a COVID-19 vaccine, he stated he had not. The first dose was administered on 04/07/2021.
This spontaneous report as received from a healthcare worker refers to multiple unspecified patients of unknown age and gender. Concurrent conditions, medical history and concomitant medication were not reported. On an unknown date, the patients were vaccinated with improperly stored doses of (Oka/Merck) VARIVAX injection (lot # K015972, expiration date 23-SEP-2015, dose and route of administration were not specified). No adverse effects were reported. Additional information is not expected as the reporter did not wish further contact.
Headache & Fever Narrative:  Employee reports having chills, fever 100.4, headache.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 58-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 12Sep2022 as dose 4 (booster), single (Lot number: GH9702) at the age of 57 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical information : The patient received paxlovid from 10May2023 till 13May2023 (lot number Gg0198) for Covid-19. Vaccine was received. Received other medications in 2 weeks.
Injection site reed and itchy, some edema warm to touch - tried ice and BENADRYL sx getting better.
Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Nausea-Mild, Systemic: Shakiness-Mild, Additional Details: PATIENT WAS TOLD BY HER PCP THAT IT WAS OK TO GET COVID VACCINE. HEP A WAS ADMINISTERED BY PCP ON 5/20/21. PATIENT WAS CONTACTED BY PHARMACY INTERN WHO ADMINISTERED VACCINE 2 HOURS LATER AND WAS TOLD THAT THE ACUTE SYMPTOMS HAD RESOLVED AND SHE WAS FEELING MUCH BETTER.
Sudden extreme fatigue about 12 hours after shot and ongoing to present.  Slept for 12 hours overnight and 1 hour in morning and 2 hours in afternoon, but still feeling extreme fatigue. Ongoing severe abdominal pain, severe muscle-aches and pain. Nausea, complete loss of appetite. Twice I felt a sharp muscle pain (like a "stitch") in upper right side of chest (in front). Injection site very sore.
Patient call Monday 07/25/2022 stating the vaccine shredded her body.  She reports having had shaking, tight chest, burning, weak and numb feeling. hot flashes, face and lips felt numb, arms and legs were really weak and dizziness.  Patient states she did not go to the Dr nor the ER felt her body could heal itself.   Patient stated Monday she was still having tightness in her chest and wouldn't recommend it to anyone.  Patient reports go to the clinic as we spoke to get an exemption form to never have another dose given.
has passed out three different times; dizziness; This is a spontaneous report from a contactable consumer. This consumer reported similar events for four patients. This is the third of four reports.  A 7-decade-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose number unknown, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced dizziness and has passed out three different times on an unspecified date. Consumer reported that her friend's boyfriend, who's 65, maybe 66, has had dizziness, and has passed out three different times. The consumer's friend stated that her boyfriend has gone to various doctors and had various tests and they can't find anything. The outcome of the events was unknown.    The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202100951538 same reporter/drug, similar events, different patient
Prevnar 13 administered in right deltoid.  Red rectangular patch appeared at injection site approximately 5 day following injection. Fluzone HD administered in left deltoid.  Arm became swollen on inside of elbow which appeared day after injection.
Pt recvd vax 20OCT93 & leg became erythematous 102 days p/vax; pt c/o leg hurting & unable to bear weight; lump under skin & bruise present; rash inc in size; pt taken to ER; poss infect or immun rxn;
On Saturday, May 4, 2019 afternoon, patient started feeling fever-like symptoms, headache, dizziness, fatigue and rash on chest.  In the evening, the patient took his temperature and it was 100.2 degrees Fahrenheit.  On Sunday, May 5, 2019, the patient presented to the clinic with diaphoresis, clammy and fatigue.  His temperature was taken by agent, clinic and was 98.3 degrees Fahrenheit.  At that time, agent brought a provider to assess the patient.  The provider was, PA.  PA measured breath sounds and determined that the patient was breathing normally.  The patient was released back to duty and instructed that if he continued to have symptoms or if they worsened, to contact our clinic or to call 911.
Not pregnant and started lactating on April 26th.  Last period was 4/14/21.   Previously had a mammogram on April 1st  which was all good.
Eythema, slight edema, and warm to touch - applied ice and gave Benadryl, advised to continue with ice and Benadryl PRN. Resolved by next day.
PATIENT DEVELOPED ITCHINESS AND WARM FLUSH ALL OVER BODY WIHTIN 20 MIUTE POST INJECTION, AND RECEIVED 50 MG BENADRYL ORAL AND 20 MG FAMOTIDINE ORAL, AND AFTER 30 MINUTES, ADVERSE REACTION HAS BEEN RESOLVED.
super dizzy; hard to walk; nausea; This is a spontaneous report from a non-contactable consumer (patient) received via the Medical Information Team. A female patient of an unspecified age (reported as patient's age: 64; unit: unspecified) received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), dose 1 via an unspecified route of administration, on 27Feb2021 (Batch/Lot number was not reported) as single dose, for COVID-19 immunisation. Medical history included ongoing blood thinner use (reported as for many years, decades). Concomitant medications included unspecified blood thinner. On 28Feb2021, the patient felt super dizzy, hard to walk at all, and has nausea. The outcome of all events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
patient was in today 2 days after receiving flu shot and said it gave her a reaction that felt like allergies, stuffy nose, itchy throat, itchy around her neck. she had some patchy looking redness on her arm and said she felt a lump at the injection site.
Acute brachial plexus neuritis of right arm.  Tdap vaccine recieved in left deltoid 3/29/07.  Developed severe pain in right shoulder/arm 4/14/07, progressed to right shoulder weakness.  Seen in Hospital Emergency Department on 4/16/07, diagnosed with acute brachial plexus neuritis.  Treated with 1 gram methyprednisolone IV daily for 3 days.  Patient had a previous similar episode of acute brachial plexus neuritis in left arm approximately 10 years previously which ocurred 2 weeks after an inluenza vaccine.
I fainted the following day.   I had facial droop from the fall and ended up getting an MRI where a 1.5 cm brain lesion was found.  I have undergone numerous test to find the source of the lesion and there is no apparent cause.  I have been referred to  a university hospital to meet with a specialist to see if the lesion could have been triggered from the vaccine.
HEADACHES DAILY SINCE VACCINE (STARTED WITH FIRST) PATIENT WAS WALKING IN HOUSE AND ALMOST FELL. MUSCLES IN THIGHS FELT LIKE THEY WERE TREMBLING, NO VISIBLE TREMBLE. PATIENT WENT TO URGENT CARE BECAUSE SHE THOUGHT IT COULD BE A BLOOD CLOT. NO DOPLER WAS DONE. THE LEG IS STILL WEAK, BUT NOW THE LEFT KNEE IS SWOLLEN WITH PAIN THAT EXTENDS ENTIRE LEG. WAITING TO HAVE MRI FLUID WAS DRAW OFF KNEE. SHE HAD CORTISONE INJECTION IN KNEE
After first shot continued ringing in both ears no-laterally started approx 2 days after and continued.; This is a spontaneous report from a contactable consumer (patient) reported that a 52-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECHC COVID-19 VACCINE, lot number: ER6204), via an unspecified route of administration, administered in arm left on 22Mar2021 (at the age of 52-years-old) as a single dose for covid-19 immunisation. The patient had known allergies with certain beta blockers and macadamias nuts. The patient had no covid-19 prior vaccination. The patient had no other vaccines in four weeks and no other medications in two weeks. The patient's concomitant medications were not reported. After first shot continued ringing in both ears no-laterally started approximately 2 days after (24Mar2021) and continued. The event resulted in disability or permanent damage. The patient did not received any treatment for the event. The patient was not tested covid-19 post vaccination. The outcome of the event was not recovered.
Received the vaccine in Left Arm on Saturday, March 20, 2021 at Mall . Slight medicinal taste after receiving shot. No pain at injection site.  Sunday, March 21, 2021 woke with a feeling of numbness in lower lip on left side only and a feeling of numbness (or heaviness) in the left eye. Later in the day fever.  Overnight - fever accompanied by joint pain.  Monday morning (03/22/21) all symptoms subsided except for the numbness in left lower lip and left eye.  Tuesday, 03/23/21, Red "Covid Arm" rash on Left upper arm around injection site.  (NO PAIN or ITCHING).   To date (04/06/21) I am still experiencing numbness in my left lower lip and a "heaviness/numbness" in my left eye.  I am scheduled to see a  GENERAL PRACTIONER  I have a NEW PATIENT appointment on Thursday, April 22nd @ 9:30.  I am concerned about having the 2nd shot on Saturday, April 17.
09:00: Upon wakening this am, left arm red, hot to touch.  Redness extending from shoulder toward elbow.  Redness approximately 2cm width x 11 cm length.
Bexsero vaccine was administered on 20JUL2023 and 2nd Bexsero vaccine was administered on 02AUG2023; This non-serious case was reported by a nurse via call center representative and described the occurrence of drug dose administration interval too short in a 18-year-old male patient who received Men B NVS (Bexsero) (expiry date 31-MAR-2024) for prophylaxis.   Concomitant products included MENINGOCOCCAL VACCINE B RFHBP/NADA/NHBA OMV (BEXSERO).   On 02-AUG-2023, the patient received the 2nd dose of Bexsero. On 02-AUG-2023, an unknown time after receiving Bexsero, the patient experienced drug dose administration interval too short (Verbatim: Bexsero vaccine was administered on 20JUL2023 and 2nd Bexsero vaccine was administered on 02AUG2023). The outcome of the drug dose administration interval too short was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 15-Aug-2023 Licensed practical nurse reported that administration of Bexsero 2 weeks apart. The reporter consented to follow-up. The patient received 2nd dose of Bexsero ealier than the recommended interval, which led to shortening of vaccine schedule.
1 day after vaccine given small red bump. Enlarged over the next 2 days- red swollen, size of man's fist.
This is a spontaneous report from a contactable consumer. A 77-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number EN6200, Expiry date Jun2021) via unspecified route of administration, administered in left arm on 21Feb2021 at 13:45 (at age of 77-year-old) as dose 2, single for COVID-19 Immunisation. Medical history included coronary heart disease, high cholesterol, Surgeries include 1959 Appendix, 1981 &1982 Hysterectomy (Partial then complete), 1991 Right Ankle operation, 1995 Right Shoulder operation, 1996 Gall Bladder, 2003 Right Carotid Artery, 2004 Colon Resection, 2007 Stent-Coronary Artery, 2011 Lumpectomy (Right breast). Concomitant medication(s) included evolocumab [(REPATHA) 140 mg/ml every 14 days ; apixaban (ELIQUIS) 5mg , 2 x daily; Ramipril 10mg (2daily); Rosuvastatin calcium (CRESTOR) 40mg (daily once) ; furosemide 20mg daily once  ;alendronate sodium (70mg , weekly once ;amlodipine besilate (5mg  twice daily) ; fluticasone propionate (FLONASE ALLERGY RELIEF) 50mg 1 spray per nostril daily ; all taken for an unspecified indication from an unspecified start date and ongoing]; acetylsalicylic acid (ASPIRIN (E.C) 81mg daily once taken ; tigecycline (HET TG) 0.4 mg as needed ; oxymetazoline hydrochloride (CLARITIN ALLERGIC)10mg ; Propranolol  20 mg (as needed) all taken for an unspecified indication, start and stop date were not reported; chondroitin sulfate, glucosamine hydrochloride (GLUCOSAMINE & CHONDROITIN [CHONDROITIN SULFATE;GLUCOSAMINE HYDROCHLORIDE](1500/1200mg, 2 daily) ; ubidecarenone (COQ-10) 100 mg daily once ; Vitamin d3  2000 IU daily once ; Pantoprazole sodium 40mg daily once taken; all taken for an unspecified indication, start and stop date were not reported. Ascorbic acid, betacarotene, biotin, calcium, chlorine, chromium, copper, cyanocobalamin, dl-alpha tocopheryl acetate, folic acid, iodine, magnesium, manganese, molybdenum, nickel, nicotinamide, pantothenic acid, phosphorus, phytomenadione, potassium, pyridoxine hydrochloride, retinol, riboflavin, selenium, silicon, thiamine, vanadium, vitamin d nos, xantofyl, zinc (CENTRUM SILVER +50) daily once taken for an unspecified indication, start and stop date were not reported; Patient previously took drugs of Penicillin, Bactrim, Celebrex, Vioxx, Sulfa Drugs, Latex, Prednisone, Tramadol and experienced allergies to it. Patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number EL9265, Expiry date not reported) via unspecified route of administration on 30Jan2021  at 15:15 (at age of 77-year-old) as dose 1, single for COVID-19 Immunisation. On 22Feb2021 at 13:00 (22 days 21 hrs 45 min after second vaccination), patient experienced headache, fever 100.4, chills, body aches. Patient did not visit to emergency room due to events. Patient did not receive any treatment due to events. The Patient under went lab test and procedures include body temperature was 100.4 degree centigrade. The Outcome of the events was Unknown  No follow-up attempts are possible. No further information is expected.
This case was reported by a other health professional via call center representative and described the occurrence of wrong vaccine administered in a 6-month-old male patient who received KINRIX (batch number AC20B235AA, expiry date unknown). On 12th February 2014, the patient received KINRIX .5 ml. On an unknown date, the dose was an unknown dose. On 12th February 2014, an unknown time after receiving KINRIX, the patient experienced wrong vaccine administered and inappropriate age at vaccine administration. On an unknown date, the outcome of the wrong vaccine administered and inappropriate age at vaccine administration were unknown. Additional information: a 6 month old patient was administered KINRIX by mistake. The patient should have received the individual DTAP and IPV vaccines instead. No adverse event occurred.
The Patient had just sat down in chair outside the pharmacy after receiving his first doe of the Pfizer Covid vaccine from the technician and he fainted and fell forward onto the floor. The technician who had gave the shot and I rushed out help him. He regained consciousness right away but he had bit his lip which made his lip bleed a little and the glasses gave him a small cut under his eye. We had him lay down for a few minutes afterward and cleaned and bandaged his small cut. His mom did mention afterward that he sometimes get dizzy when he has blood drawn. This was never stated on the patient questionnaire. The patient waited the required time after the vaccine and said he no longer felt dizzy and felt fine. We put notes on patient's file of the event and to walk him to his seat and observe him closely with his 2nd dose.
Left facial weakness and face droop that started on 3/28/17 - to be started on acyclovir and prednisone today (3/29/17).
no adverse event; administered an impropery stored dose of PEDVAX HIB; This spontaneous report was received from a nurse regarding a patient of unknown age and gender. Patient's pertinent medical history, concurrent conditions, past drugs, allergies and concomitant therapies were not reported. On 07-APR-2020, the patient was vaccinated with improperly stored haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) (strength, dose and route were not reported) (lot number S023645 and expiration date 10-MAR-2022) for prophylaxis (product storage error). The temperature excursion was noted with a temperature of 51.5 Fahrenheit (F) for 45 minutes. There was no previous temperature excursion. No adverse effects were reported. The call was because of digital data logger. No product quality complaint was reported.  This is one of the several reports received from the same reporter.; Sender's Comments:  US-009507513-2005USA002553:
24 hours of chills, myalgia, headache, fatigue. Max temp 99.6
Thurs had small rash on finger by Saturday all over hands also noted pink radish rash at the injection site Sunday moved on arms feet around on face
Patient hugged a military recruit who had received smallpox vaccination 2 days prior to her hugging him (3/24/2003). 4-5 days after, patient developed macular/papular lesions on her leg. APproximately 8-10 lesions.  Patient sought care at a civilian ER and was counseled to keep lesions covered.
102.6 temp, nausea, vomiting, severe chills, weak, severe fatigue, achy, shortness of breath Lasted 5 days
Gross hematuria for 3 days after the 2nd and 3rd doses (1st and 2nd boosters). Hematuria was not observed after initial dose. Subject was worked for hematuria, complete blood works including Complement (C3 and C4), total protein/creatinine ratio, APTT, PROTIME-INR, renal function panel, urinanalysis, calcium/random urine, urine culture, and kidney ultrasound. No treatment given. Gross hematuria resolved within 3 days and proteinuria persisted for about 3 months before resolving. Same follow done after 2nd booster and proteinuria follow up is still pending.
pt recv vax 5JUL96 & 7JUL96 pt exp petechial eruption which was found to be a viral exanthem;there was no evidence of vasculitis & no therapy was given;sx resolved;
The patient given a pediatric COVID-19 vaccine dose instead of the adult dose. The patient had no adverse reaction.